Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Acalabrutinib for the Treatment of Chronic Graft Versus Host Disease

Miscellaneous

A Study Evaluating an Advanced Pneumatic Compression Device Versus Usual Care for Treatment of Head and Neck Lymphedema

Head/Neck

APOLLO-B Expanded Access Protocol ALN-TTR02-014 Expanded Access Protocol to Provide Patisiran to Patients with Transthyretin-mediated Amyloidosis (ATTR Amyloidosis) with Cardiomyopathy

REDUCE LAP II- A study to evaluate the Corvia Medical Inc IASD system II REDUCE Elevated Left Atrial Pressure in Patients with Hear Failure

ION-682884-CS2 - A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

PROACTIVE - HF Trial: A Prospective, Multi-Center, Open Label, Single Arm Clinical Trial Evaluating the Safety and Efficacy of the Cordella; Pulmonary Artery Sensor System in New York Heart Association (NYHA) Class III Heart Failure Patients

ALL-IN - Targeting Inflammation and Alloimmunity in Heart Transplant Recipients with Tocilizumab

LESS VT- Flexibility Sensor Enabled Substrate Targeted Ablation for teh Reduction of VT (LESS VT) Study

VANISH 2- Ventricular Tachycardia Antiarrhythmics or Ablation in Structural Heart Disease 2

SOS-AMI - Protocol ID-07-076A301 Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI)
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction